Federal Agency · National Institutes of Health
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
Posted October 31, 2024
Funding
Funding amount not specified
Closes
June 2, 2027
NAICS
541714
The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precision probiotic interventions using a milestone-driven, biphasic award mechanism, R61/R33 Phased Innovation Award. Specifically, this NOFO solicits applications that will characterize person-specific features affecting probiotic responses to identify subgroups of probiotic responders and to enhance probiotic clinical outcomes.
Eligibility
Funded by NIH and Programs related to transit.
Award details
Applications close on June 2, 2027 (400 days remaining).
Categories
Research Innovation
Sign up at GrantRegister to see if this grant matches your organization.
Match my organization →View application on Grants.gov →·Source: Grants.gov·Last seen Apr 28, 2026